P1055: BROMODOMAIN AND EXTRA‐TERMINAL (BET) INHIBITOR INCB057643 (LIMBER‐103) IN PATIENTS (PTS) WITH RELAPSED OR REFRACTORY MYELOFIBROSIS (R/R MF) AND OTHER ADVANCED MYELOID NEOPLASMS: A PHASE 1 STUDY
Watts, Justin M., Hunter, Anthony M., Iurlo, Alessandra, Xicoy, Blanca, Palandri, Francesca, Reeves, Brandi, Vannucchi, Alessandro, Bose, Prithviraj, Ayala Diaz, Rosa, Halpern, Anna B., Chen, Xuejun, Seguy, Francis, Zhou, Feng, Zheng, Fred, Vachhani, Pankit
Published in HemaSphere (08.08.2023)
Published in HemaSphere (08.08.2023)
Get full text
Journal Article
Development of 2 Bromodomain and Extraterminal Inhibitors With Distinct Pharmacokinetic and Pharmacodynamic Profiles for the Treatment of Advanced Malignancies
Falchook, Gerald, Rosen, Seth, LoRusso, Patricia, Watts, Justin, Gupta, Shilpa, Coombs, Catherine C, Talpaz, Moshe, Kurzrock, Razelle, Mita, Monica, Cassaday, Ryan, Harb, Wael, Peguero, Julio, Smith, David C, Piha-Paul, Sarina A, Szmulewitz, Russ, Noel, Marcus S, Yeleswaram, Swamy, Liu, Phillip, Switzky, Julie, Zhou, Gongfu, Zheng, Fred, Mehta, Amitkumar
Published in Clinical cancer research (15.03.2020)
Published in Clinical cancer research (15.03.2020)
Get full text
Journal Article
INCB057643 Monotherapy in Patients with Relapsed or Refractory Myelofibrosis: A Phase 1 Study
Watts, Justin, Hunter, Anthony M., Iurlo, Alessandra, Xicoy, Blanca, Palandri, Francesca, Reeves, Brandi, Vannucchi, Alessandro M., Chen, Xuejun, Seguy, Francis, Zhou, Feng, Zheng, Fred, Vachhani, Pankit
Published in Blood (15.11.2022)
Published in Blood (15.11.2022)
Get full text
Journal Article
Bromodomain and extra-terminal (BET) inhibitor INCB057643 (LIMBER-103) in patients (pts) with relapsed or refractory myelofibrosis (R/R MF) and other advanced myeloid neoplasms: A phase 1 study
Watts, Justin M., Hunter, Anthony, Iurlo, Alessandra, Xicoy, Blanca, Palandri, Francesca, Reeves, Brandi, Vannucchi, Alessandro M., Bose, Prithviraj, Diaz, Rosa Ayala, Halpern, Anna B., Chen, Xuejun, Seguy, Francis, Zhou, Feng, Zheng, Fred, Vachhani, Pankit
Published in Journal of clinical oncology (01.06.2023)
Published in Journal of clinical oncology (01.06.2023)
Get full text
Journal Article
Bromodomain and extra-terminal (BET) inhibitor INCB057643 in patients with relapsed or refractory myelofibrosis (MF) and other advanced myeloid neoplasms: A phase 1 study
Watts, Justin M., Vannucchi, Alessandro M., Hunter, Anthony, McMahon, Brandon, Tantravahi, Srinivas Kiran, Iurlo, Alessandra, Xicoy, Blanca, Palandri, Francesca, Searle, Emma, Reeves, Brandi, Bose, Prithviraj, Diaz, Rosa Ayala, Halpern, Anna B., Chen, Xuejun, Burke, Lea Micaletti, Zhou, Feng, Zheng, Fred, Vachhani, Pankit
Published in Journal of clinical oncology (01.06.2024)
Published in Journal of clinical oncology (01.06.2024)
Get full text
Journal Article
Epacadostat Plus Pembrolizumab and Chemotherapy for Advanced Solid Tumors: Results from the Phase I/II ECHO-207/KEYNOTE-723 Study
Powderly, John D, Klempner, Samuel J, Naing, Aung, Bendell, Johanna, Garrido-Laguna, Ignacio, Catenacci, Daniel V T, Taylor, Matthew H, Lee, James J, Zheng, Fred, Zhou, Feng, Gong, Xiaohua, Gowda, Hema, Beatty, Gregory L
Published in The oncologist (Dayton, Ohio) (03.11.2022)
Published in The oncologist (Dayton, Ohio) (03.11.2022)
Get full text
Journal Article
Bromodomain and Extra-Terminal Inhibitor INCB057643 (LIMBER-103) in Patients with Relapsed or Refractory Myelofibrosis and Other Advanced Myeloid Neoplasms: A Phase 1 Study
Watts, Justin M., Vannucchi, Alessandro M., Hunter, Anthony M., McMahon, Brandon, Tantravahi, Srinivas K., Iurlo, Alessandra, Xicoy, Blanca, Palandri, Francesca, Searle, Emma, Reeves, Brandi N., Bose, Prithviraj, Ayala, Rosa, Halpern, Anna B., Chen, Xuejun, Burke, Lea M, Zhou, Feng, Zheng, Fred, Vachhani, Pankit
Published in Blood (02.11.2023)
Published in Blood (02.11.2023)
Get full text
Journal Article
A phase II trial to evaluate the efficacy of fostamatinib in patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL)
Flinn, Ian W, Bartlett, Nancy L, Blum, Kristie A, Ardeshna, Kirit M, LaCasce, Ann S, Flowers, Christopher R, Shustov, Andrei R, Thress, Kenneth S, Mitchell, Patrick, Zheng, Fred, Skolnik, Jeffrey M, Friedberg, Jonathan W
Published in European journal of cancer (1990) (01.02.2016)
Published in European journal of cancer (1990) (01.02.2016)
Get full text
Journal Article
Efficacy and Safety of Parsaclisib in Patients with Relapsed or Refractory Mantle Cell Lymphoma Not Previously Treated with a BTK Inhibitor: Primary Analysis from a Phase 2 Study (CITADEL-205)
Mehta, Amitkumar, Trněný, Marek, Walewski, Jan, Ribrag, Vincent, Dartigeas, Caroline, Christensen, Jacob Haaber, Pane, Fabrizio, Rodriguez, Guillermo, Taszner, Michal, Venugopal, Parameswaran, Zilioli, Vittorio Ruggero, Zheng, Fred, DeMarini, Douglas J, Jiang, Wei, Zinzani, Pier Luigi Luigi
Published in Blood (23.11.2021)
Published in Blood (23.11.2021)
Get full text
Journal Article
Efficacy and Safety of Parsaclisib in Patients with Relapsed or Refractory Marginal Zone Lymphoma: Primary Analysis from a Phase 2 Study (CITADEL-204)
Phillips, Tycel, Avigdor, Abraham, Gurion, Ronit, Patti, Caterina, Corradini, Paolo, Tani, Monica, Mehta, Amitkumar, Lossos, Izidore S., Zinzani, Pier Luigi Luigi, Thieblemont, Catherine, Jurczak, Wojciech, Zheng, Fred, Rappold, Erica, Zhao, Wanying, Johnson, Peter
Published in Blood (23.11.2021)
Published in Blood (23.11.2021)
Get full text
Journal Article
Bromodomain and Extra-Terminal (BET) Inhibitor INCB057643 in Patients With Relapsed or Refractory Myelofibrosis and Other Advanced Myeloid Neoplasms: A Phase 1 Study
Vachhani, Pankit, Vannucchi, Alessandro M., Hunter, Anthony M., McMahon, Brandon, Tantravahi, Srinivas K., Iurlo, Alessandra, Xicoy, Blanca, Palandri, Francesca, Searle, Emma, Reeves, Brandi, Bose, Prithviraj, Ayala Diaz, Rosa, Halpern, Anna B., Chen, Xuejun, Burke, Lea, Zhou, Feng, Zheng, Fred, Watts, Justin
Published in Clinical lymphoma, myeloma and leukemia (01.09.2024)
Published in Clinical lymphoma, myeloma and leukemia (01.09.2024)
Get full text
Journal Article
MPN-112 Bromodomain and Extra-terminal (BET) Inhibitor INCB057643 in Patients With Relapsed or Refractory Myelofibrosis and Other Advanced Myeloid Neoplasms: A Phase 1 Study
Vachhani, Pankit, Vannucchi, Alessandro M., Hunter, Anthony M., McMahon, Brandon, Tantravahi, Srinivas K., Iurlo, Alessandra, Xicoy, Blanca, Palandri, Francesca, Searle, Emma, Reeves, Brandi, Bose, Prithviraj, Ayala Diaz, Rosa, Halpern, Anna B., Chen, Xuejun, Burke, Lea, Zhou, Feng, Zheng, Fred, Watts, Justin
Published in Clinical lymphoma, myeloma and leukemia (01.09.2024)
Published in Clinical lymphoma, myeloma and leukemia (01.09.2024)
Get full text
Journal Article
Phase 2 Study Evaluating the Efficacy and Safety of Parsaclisib in Patients with Relapsed or Refractory Marginal Zone Lymphoma (CITADEL-204)
Phillips, Tycel J., Corradini, Paolo, Gurion, Ronit, Patti, Caterina, Tani, Monica, Avigdor, Abraham, Jurczak, Wojciech, Mehta, Amitkumar, Zinzani, Pier Luigi, Lossos, Izidore S., Thieblemont, Catherine, Zheng, Fred, Rappold, Erica, Zhao, Wanying, Johnson, Peter
Published in Blood (05.11.2020)
Published in Blood (05.11.2020)
Get full text
Journal Article
Phase 2 Study Evaluating the Efficacy and Safety of Parsaclisib in Patients with Relapsed or Refractory Follicular Lymphoma (CITADEL-203)
Lynch, Ryan C., Paneesha, Shankara, Avigdor, Abraham, McKinney, Matthew S, Wahlin, Björn E, Hrom, John S, Belada, David, Canales, Miguel, Cunningham, David, Devizzi, Liliana, Morley, Nicholas, Zheng, Fred, DeMarini, Douglas J, Jiang, Wei, Trněný, Marek
Published in Blood (05.11.2020)
Published in Blood (05.11.2020)
Get full text
Journal Article
Phase 2 Study Evaluating the Efficacy and Safety of Parsaclisib in Patients with Relapsed or Refractory Mantle Cell Lymphoma Not Previously Treated with a BTK Inhibitor (CITADEL-205)
Mehta, Amitkumar, Trněný, Marek, Walewski, Jan, Ribrag, Vincent, Dartigeas, Caroline, Christensen, Jacob Haaber, Pane, Fabrizio, Rodríguez, Guillermo, Taszner, Michal, Venugopal, Parameswaran, Zilioli, Vittorio Ruggero, Zheng, Fred, DeMarini, Douglas J, Jiang, Wei, Zinzani, Pier Luigi
Published in Blood (05.11.2020)
Published in Blood (05.11.2020)
Get full text
Journal Article
Phase 2 Study Evaluating the Efficacy and Safety of Parsaclisib in Patients with Relapsed or Refractory Mantle Cell Lymphoma Previously Treated with Ibrutinib (CITADEL-205)
Zinzani, Pier Luigi, Delwail, Vincent, Paneesha, Shankara, Rule, Simon, Martin Garcia-Sancho, Alejandro, Marin-Niebla, Ana, Salles, Gilles, Sancho, Juan-Manuel, Vergote, Vibeke, Zilioli, Vittorio Ruggero, Zheng, Fred, DeMarini, Douglas J, Jiang, Wei, Mehta, Amitkumar
Published in Blood (05.11.2020)
Published in Blood (05.11.2020)
Get full text
Journal Article
Bromodomain and extra-terminal inhibitors—A consensus prioritisation after the Paediatric Strategy Forum for medicinal product development of epigenetic modifiers in children—ACCELERATE
Pearson, Andrew DJ, DuBois, Steven G., Buenger, Vickie, Kieran, Mark, Stegmaier, Kimberly, Bandopadhayay, Pratiti, Bennett, Kelly, Bourdeaut, Franck, Brown, Patrick A., Chesler, Louis, Clymer, Jessica, Fox, Elizabeth, French, Christopher A., Germovsek, Eva, Giles, Francis J., Bender, Julia G., Hattersley, Maureen M., Ludwinski, Donna, Luptakova, Katarina, Maris, John, McDonough, Joe, Nikolova, Zariana, Smith, Malcolm, Tsiatis, Athanasios C., Vibhakar, Rajeev, Weiner, Susan, Yi, Joanna S., Zheng, Fred, Vassal, Gilles
Published in European journal of cancer (1990) (01.03.2021)
Published in European journal of cancer (1990) (01.03.2021)
Get full text
Journal Article
MPN-559 Bromodomain and Extra-Terminal (BET) Inhibitor INCB057643 (LIMBER-103) in Patients With Relapsed or Refractory Myelofibrosis (R/R MF) and Other Advanced Myeloid Neoplasms: A Phase I Study
Watts, Justin, Hunter, Anthony, Iurlo, Alessandra, Xicoy, Blanca, Palandri, Francesca, Reeves, Brandi, Vannucchi, Alessandro, Bose, Prithviraj, Diaz, Rosa, Halpern, Anna, Chen, Xuejun, Burke, Lea, Zhou, Feng, Zheng, Fred, Vachhani, Pankit
Published in Clinical lymphoma, myeloma and leukemia (01.09.2023)
Published in Clinical lymphoma, myeloma and leukemia (01.09.2023)
Get full text
Journal Article